Abstract:Live vector-based vaccine is a modern approach to overcome the drawbacks of inactivated foot-and-mouth disease (FMD) vaccines such as improper inactivation during manufacture. Listeria monocytogenes (LM), an intracellular microorganism with immune-stimulatory properties, is appropriate to be utilized as a live bacterial vaccine vector. FMDV-VP1 protein has the capability to induce both cellular and humoral immune responses since it is considered the most immunogenic part of FMDV capsid and has the most of antigenic sites for viral neutralization. The codon-optimized vp1 gene was ligated to the integrative pCW702 plasmid to construct the target cassette. The antigen cassette was integrated successfully into the chromosome of mutant LM strain via homologous recombination for more stability to generate a candidate vaccine strain LM△actAplcB-vp1. Safety evaluation of recombinant LM△actAplcB-vp1 revealed it could be eliminated from the internal organs within 3 days as a safe candidate vaccine. Mice groups were immunized I.V. twice with the recombinant LM△actAplcB-vp1 at an interval of 2 weeks. Antigen-specific IgG antibodies and the level of CD4+- and CD8+-specific secreted cytokines were estimated to evaluate the immunogenicity of the candidate vaccine. The rapid onset immune response was detected, strong IgG humoral immune response within 14 days post immunization and augmented again after the booster dose. Cellular immunity data after 9 days post the prime dose indicated elevation in CD4+ and CD8+ secreted cytokine level with another elevation after the booster dose. This is the first report to explain the ability of attenuated mutant LM to be a promising live vector for FMDV vaccine.

Construction and Identification of Recombinant Adenovirus Expression VP1 of Foot and Mouth Disease Virus

Development of Tobacco necrosis virus A as a vector for efficient and stable expression of FMDV VP1 peptides.

Prokaryotic Expression and Activity Analysis of VP1 of Foot-and-Mouth Disease Virus Serotype A

Expression and immunogenicity of recombinant fusion protein comprising foot-and-mouth disease virus structural protein VP1 and intercellular adhesion molecule ICAM-2

Prokaryotic Expression and Activity Analysis of VP1 Gene of Foot-and-Mouth Disease Virus Serotype O

Construction and Immunogenicity Evaluation of Recombinant Adenovirus-Expressing Capsid Protein of Foot-and-Mouth Disease Virus Types O and A

Prokaryotic Expression of Structural Protein VP1 of Foot-and-mouth disease virus Type O and Analysis of Its Antigenicity

Immunogenicity analysis of the E. coli expressed structural protein VP1 of persistent infection foot-and-mouth disease virus

Immunogenicity of Recombinant Fowl-Pox Virus Co-Expressing Structural Protein Precursor P1-2A and Proteinase 3C of FMDV

Detection of Foot-and-mouth Virus Antibodies Using a Purified Protein from the High-Level Expression of Codon-Optimized, Foot-and-mouth Disease Virus Complex Epitopes in Escherichia Coli.

High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha.

Soluble FMDV VP1 Proteins Fused with Calreticulin Expressed in Escherichia Coli under the Assist of Trigger Factor16 (tf16) Formed into High Immunogenic Polymers.

Cloning and Prokaryotic Expression of VP1 Gene of Foot-and-Mouth Disease Virus (FMDV) Type O

Expression and Immunogenicity of Two Recombinant Fusion Proteins Comprising Foot-and-Mouth Disease Virus Structural Protein VP1 and DC-SIGN-Binding Glycoproteins

Expression,Purification and Identification of 3D Protein N Terminal T Cell Epitope Recombinant Protein of Foot and Mouth Disease Virus

Construction of Recombinant Adenovirus Containing Pocine IFN-α Genes and Activity of Anti-Swine Foot-and-mouth Disease Virus

Development of recombinant vp1 protein immunised in mice as a model of foot-and-mouth disease vaccine

Protective Immune Responses Against Foot-And-Mouth Disease Virus by Vaccination with A Dna Vaccine Expressing Virus-Like Particles

Recombinant Expression and Activity Identification of 3D Protein C Terminal Th Epitope Peptides of Foot and Mouth Disease Virus

Expression of the VP1 protein of FMDV integrated chromosomally with mutant Listeria monocytogenes strain induced both humoral and cellular immune responses

Development of an Indirect ELISA Based on VP1-CRT Fusion Protein for Detection of FMDV-O in Swine